WOCKPHARMANSEWockhardt Limited· PharmaceuticalsHighPositive
Announced Thu, 21 May · 14:24 IST

Wockhardt Limited has informed the Exchange about Credit Rating

Rating UpgradedCredit & Debt View source PDF

WOCKPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.2%1-day move
₹1613.00
prior close
₹1602.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.0-0.2-0.3-2.2+2.0+6.3+10.4+25.5+22.3+20.0+24.9+17.2
Up moveDown movePending
AI summary

ICRA Limited has upgraded Wockhardt's credit ratings across all its debt instruments from BBB (Positive) to A- (Stable), with short-term ratings also upgraded to A2+. This upgrade reflects the company's improved financial performance, strong market position in formulations in India and Europe, growing presence in emerging markets, adequate liquidity, and a comfortable capital structure. The rating agency also cited scale expansion of value-accretive products and new chemical entities (NCEs) as positive factors.

Likely market impact

This is a positive development for shareholders as the upgrade signals improved creditworthiness and financial health, which could lower borrowing costs and boost investor confidence in the stock.